Home / Inspections / 1222597

FDA Inspection 1222597 — Imaging Endpoints II, LLC

Imaging Endpoints II, LLC — FEI 3014319173

The FDA completed an inspection of Imaging Endpoints II, LLC on October 25, 2023 in Scottsdale, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 25, 2023
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Scottsdale, AZ (United States)

Additional Details

Sponsor, Contract Research Organization

Facility

Other inspections at this facility

  • 1309166 (NAI Thu Mar 12 2026 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1266886 (NAI Fri Apr 04 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1136122 (NAI Fri Feb 12 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1056608 (NAI Thu Jun 07 2018 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources